Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
Dror MevorachEmilia AnisNoa CedarMichal BrombergEric J HaasEyal NadirSharon Olsha-CastellDana AradTal HasinNir LeviRabea AslehOffer AmirKaren MeirDotan CohenRita DichtiarDeborah NovickYael HershkovitzRon DaganIris LeitersdorfRonen Ben-AmiIan MiskinWalid SalibaKhitam MuhsenYehezkel LeviManfred S GreenLital Keinan-BokerSharon Alroy-PreisPublished in: The New England journal of medicine (2021)
The incidence of myocarditis, although low, increased after the receipt of the BNT162b2 vaccine, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.